Polymorphous ventricular tachycardia: clinical characterization, therapy, and the QT interval

Area of Science:

• Cardiology
• Electrophysiology
• Pharmacology

Background:

• Polymorphous ventricular tachycardia (PVT) is a significant arrhythmia.
• Causes of PVT include drug toxicity and electrolyte imbalances.
• Underlying cardiac conditions can coexist with PVT.

Purpose of the Study:

• To investigate the causes and effective management strategies for polymorphous ventricular tachycardia (PVT).
• To evaluate the role of the QT interval in PVT occurrence and treatment response.
• To assess the efficacy of various antiarrhythmic drugs and pacing in PVT management.

Main Methods:

• Retrospective analysis of 45 consecutive patients diagnosed with polymorphous ventricular tachycardia (PVT).
• Categorization of PVT causes, including drug-related, electrolyte disorders, and cardiac conditions.
• Evaluation of treatment responses to antiarrhythmic drugs (Type I, amiodarone) and cardiac pacing.

Main Results:

• Drug-induced causes accounted for the majority of PVT cases (27/45).
• Cardiac pacing demonstrated high efficacy in short-term management of drug-induced PVT.
• Type I antiarrhythmic drugs often aggravated PVT, while amiodarone showed long-term efficacy in select patients.

Conclusions:

• Identifying the cause of PVT is crucial for effective treatment.
• The QT interval is not consistently predictive of PVT occurrence or treatment success.
• Temporary cardiac pacing is a reliable short-term solution, and amiodarone offers a potential long-term therapeutic option for specific PVT cases.